After 16 weeks, your provider may continue at 10 mg maintenance, or escalate to 15 mg if weight loss has plateaued and you have tolerated the medication well
There appear to be multiple pathways that GLP-1 agonists directly and indirectly target that cause a multitude of downstream effects in terms of immune, inflammatory and cellular health as Ive just highlighted
If there's anyone fantastic in your network that we should meet, please let us know!Transcend Therapeutics Transcend Therapeutics 8moBlake Mandell shared thisWere hiring
If you are considering stopping GLP-1 therapy, discuss a structured monitoring plan with your GP or specialist, including regular checks of HbA1c, weight, blood pressure and lipids
for providing a license to GastroPlus under the SLP University+ program ( Ethics declarations Competing interests The authors declare no competing interests